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PrnB is a heme-containing enzyme, which catalyzes the ring rearrangement
reaction of 7-chlorotryptophan to produce 3-(3-Chloro-2-nitrophenyl)pyrrole. This thesis
describes the initial isolation and characterization of PrnB, the second enzyme associated
with the pyrrolnitrin biosynthetic pathway in Burkholderia ambifaria. Additionally,
alternative peroxidase reactivity was used to study how amino-acids bind to the substrate
binding pocket of PrnB. The peroxidase activity of PrnB was measured using three
different peroxidase activity assays at various pH values. The peroxidase data was
compared to similar studies with the classic peroxidase, Horseradish peroxidase (HRP).
Generally, PrnB showed weak peroxidase reactivity. However this weak reactivity was
an experimental handhold, where tryptophan and other substrate binding events can be
explored using classic inhibition steady-state kinetics. The rate of 2-aminophenol
oxidation by PrnB was used as a model assay to monitor how molecules such as Ltryptophan, L-alanine, indole, L-phenylalanine, and L-tyrosine interact with the PrnB
active site.
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CHAPTER I
INTRODUCTION

1.1

Burkholderia ambifaria and cystic fibrosis
Bacteria often coordinate their activities and act in a concerted manner similar to

multi-cellular organisms. Many Gram-negative bacteria produce signal molecules, which
are used to monitor their own population densities in a process known as ‘quorumsensing.’ These regulatory systems have been identified in a variety of Gram-negative
species in which they regulate functions related to virulence, biofilm formation, and the
production of antimicrobial compounds. In the Burkholderia cepacia complex (BCC), a
series of extracellular enzymes, siderophores, toxins, and antimicrobial molecules are
generated as a part of a combined biological response regulated by quorum-sensing. This
cascade of extracellular molecules act in part to suppress competing micro-organisms,
and allow the antibiotic resistant members of the BCC to flourish in the mucous airways
of individuals with cystic fibrosis, where it is known to act as an opportunistic pathogen
and lead to rapid clinical decline.
Recently the preliminary draft of the genome of Burkholderia ambifaria (BCC
genomovar VII) has been reported, and a pyrrolnitrin biosynthetic gene cluster
(prnABCD) has been identified, which has been shown to be regulated by quorumsensing. From this data, the mechanism of pyrrolnitrin biosynthesis and how this pathway
contributes to cellular proliferation have attracted us because through this detailed
1

mechanistic study can lead us to identify a series of small, non-antibiotic compounds that
inhibit this pathway in vitro. We plan to apply these inhibitor complexes to active
cultures of Burkholderia ambifaria and other BCC species to determine how the
inhibition of pyrrolnitrin affects bacterial growth and biofilm formation. Leveraged
against the knowledge in enzymology, we will gain deeper understanding pyrrolnitrin
biosynthesis and how this pathway affects B. ambifaria proliferation. Our efforts to
inhibit the pyrrolnitrin biosynthetic pathway will become a precedent for further
investigation in to possible new non-antibiotic molecules that target the pathways
regulated by quorum-sensing in the BCC, and will lead to new treatment options for
individuals infected with antibiotic resistant bacterial infections such as the chronic BCC
infections found in some cystic fibrosis patients.
1.2

Biosynthetic pathway of pyrrolnitrin
Pyrrolnitrin (3-chloro-4-(2′-nitro-3′-chlorophenyl)pyrrole (Figure 1.1) is a well

known and broadly used antifungal compound, which was first isolated from
Pseudomonas pyrrocinia in 1964.1 Pyrrolnitrin is a secondary metabolite generated in a
four-step enzymatic pathway, which requires the enzymes: PrnA, PrnB, PrnC, and PrnD
(Figure 1.2).2
The pyrrolnitrin biosynthetic gene cluster was first identified in 1997 by van Peé
and co-workers, who identified this gene cluster from Pseudomonas fluorescens BL915.3
The genomic DNA fragment associated with pyrrolnitrin biosynthesis was isolated from
this strain, and four genes (prnABCD) were identified (Figure 1.3). When the prnABCD
gene cluster was ligated into a bacterial expression vector, it afforded E. coli the ability to
generate observable extracellular amounts of pyrrolnitrin.3,4
2

The proteins generated from the P. fluorescens prnABCD cassette have been
recombinately isolated and to some extent characterized. PrnA is a regioselective
tryptophan halogenase, involved in the first step of pyrrolnitrin biosynthesis. This
enzyme catalyzes the incorporation of chlorine into the 7 position of the indole ring of
tryptophan. Discovered in 1997 by a genetic approach, it was then realized that the
protein required FADH for the catalysis of the halogenation reaction.5 The PrnA
monomer is a single domain protein, formed by a parallelepiped “box” with a
triangular “pyramid” leaning on one side of it (Figure 1.4). Sequence alignments show
that only the flavin binding module is conserved in the halogenase superfamily.6 The
flavin binding module of PrnA also shows significant similarity to the structure of phydroxybenzoate hydroxylase (PHBH) from Pseudomonas fluorescens.6 The structural
similarity to flavin-dependent monooxygenases helped to formulate a reaction
mechanism for PrnA. The mechanism of these monooxygenases is well established.7,8
The enzyme is first reduced to give a FADH2 co-factor, which then binds molecular
oxygen to form a spectroscopically characterized highly reactive peroxide-linked flavin.
This reactive intermediate is decomposed by the nucleophilic attack of an adjacent
aromatic substrate, resulting in the transfer of an oxygen atom.
The proposed mechanism of PrnA starts with a FADH2 unit that binds molecular
oxygen forming the same peroxide-linked isoalloxazine ring which is shown in Figure
1.5. However, in PrnA there is no room for an organic molecule to bind adjacent to the
isoalloxazine ring, due to the presence of the conserved tryptophan residues W272 and
W274. In PrnA a chloride ion (Cl-) is ideally positioned to make a nucleophilic attack on
the flavin peroxide, resulting in the formation of hydroxylated FAD unit and hypochlorite
3

(HOCl). After HOCl is formed, it is prevented from diffusing into solvent by the protein
structure and guided through a tunnel in the enzyme allowing it to attack a bound
tryptophan molecule. In the native PrnA structure, K79 makes a hydrogen bond with a
water molecule located at the end of the tunnel adjacent to the Cl atom of 7chlorotrypotphan as shown in Figure 1.6. The controlled spatial presentation of HOCl to
substrate has been proposed as the base for regioselective halogenation.6, 9
The prnC gene product is a 65 KDa protein (567aa), which chlorinates monodechloroaminopyrrolnitrin at position 3 of the pyrrole ring to form aminopyrrolnitrin.
Like PrnA, PrnC contains an FAD-dependent halogenase motifs, which suggests that the
two enzymes work in a similar way.3,10 The amino-acid sequences of the two chlorinating
enzymes PrnC and PrnA, however, have only 18 % identity and 26 % similarity. The low
sequence similarity could explain the different substrate specificity.
PrnD is proposed to catalyze the final oxidation step of pyrrolnitrin biosynthesis,
where the amino group of aminopyrrolnitrin is converted to a nitro group. The sequence
similarities suggest PrnD is a member of a non-heme iron enzymes family that contains a
Rieske type Fe-S center known as the Rieske oxygenases. However, PrnD shows less
than 20% homology to any known oxygenase structure and performs completely different
chemistry.3,10 First attempts to obtain PrnD over-expression in E.coli led to production of
insoluble protein.10 More recently soluble MBP (Maltose Binding Protein) tagged prnD
over-expression in E.coli has been reported together with the cleavage of the MBP tag
and reconstitution of the iron sulphur cluster.11 Availability of reconstituted
enzymatically active prnD helped to propose the first enzyme mechanism for the
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conversion of arylamines into arylnitro compounds in which the enzyme catalyzes at least
three consecutive reactions shown in Figure 1.7.12
Finally, PrnB has been proposed to catalyze the second step of the pyrrolnitrin
biosynthetic pathway, which consists of the novel ring rearrangement reaction where 7Cl-tryptophan is converted to 3-(3-chloro-2-nitrophenyl)pyrrole. It has been reported that
this enzyme can rearrange the ring systems in tryptophan directly.10 PrnB contains 361
amino-acids with a molecular weight of approximately 39 KDa. It is a heme-dependent
enzyme and thought to be a member of dioxygenase superfamily.2 This assignment is
based on the significant structural homology between PrnB and the heme-dioxygenases
indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO). The initial
X-ray crystal structure of PrnB was reported by De Laurentis et al. (Figure 1.8).2
It is generally thought that PrnB catalyzes the ring rearrangement reaction of 7Cl-tryptophan to monodechloroaminopyrrolnitrin. However this activity has been only
observed in vivo and has yet to be uncovered in vitro. There could be many reasons for
the lack of observable activity: there could be unknown cofactors required for activity or
perhaps PrnB may need to interact with other enzymes to adapt to an active form of the
enzyme. Although the native catalytic activity cannot be performed in vitro, alternative
reactivities can be used to probe the mechanism of PrnB. Herein we report our studies of
peroxidase-like activity associated with PrnB. This peroxidase reactivity can be used as
model reactivity to investigate substrate interaction with PrnB, which affords unique
insight into the catalytic properties of PrnB. The peroxidase reactivity of PrnB was
investigated at different pH values, and a number of inhibition studies of PrnB were
conducted. Additional reactivities such as epoxidation of olefins were also explored with
5

limited success. In the following chapter, we describe the over-expression, purification,
in vitro peroxidase activity at different pH, and inhibition studies of PrnB. Together the
data collected from these experiments will give a better understanding about the working
mechanism of PrnB.
1.3

Heme and heme environment
Hemes are biological prosthetic groups widely used in nature to perform diverse

range of biological functions. Heme containing enzymes have been intensely studied over
the last 50 years because of their versatility. Heme enzymes mainly perform three
functions: (1) They support catalysis of peroxide and oxygen-dependent redox reactions
(e.g., cytochromes P450, catalases, peroxidases, and catalase-peroxidases), (2) They
reversibly bind oxygen and are utilized in storage and transport proteins (e.g.,
hemoglobin, and myoglobin), and (3) They are used in electron transfer proteins (e.g.,
cytochromes P450).13
In the structure of heme, a tetrapyrrole macrocycle ring is complexed with iron
(Figure 1.9), where the four equatorial ligands are derived from the porphyrin nitrogens.
The remaining two coordination sites on a pseudo-octahedral iron are trans to one
another. These axial coordination sites lie above and below the plane of the heme. The
most commonly observed heme is heme b (iron protoporphyrin IX), which is found in btype cytochromes, hemoglobins, myoglobins, cytochromes P450, and hemesensor
proteins.
The diversity of the protein-derived ligands plays an important role in controlling
the versatility of heme-dependent enzymes. Histidine is a widely used coordination
ligand. Among heme-enzymes, the most common iron binding motif is a five-coordinate
6

complex where the iron is in pseudo-octahedral coordination geometry with one open
site. The four porphyrin derived ligand occupy the equatorial positions and an axial
histidine coordinates Trans to the open binding site. This is often termed the proximal
ligand. This metal binding motif is observed in hemoglobin and myoglobin. Very few
amino-acids other than histidine are observed in this coordination mode. Exceptions
include a thiolate ligation, where the proximal position is a cysteine residue. This
modified binding motif is observed in cytochromes P450 and nitric oxide synthase, and
tyrosine phenozide in heme catalase.
The second most common motif is hexa-coordinate with bis-histidine
coordination, followed by hexacoordinate with histidine and methionine, as in
cytochromes c.14 All other combinations of coordination ligands are relatively rare, such
as the histidine and lysine combination observed in cytochrome f.
In addition to properties of hemes themselves and the protein-derived ligands
attached to them, the local protein environment of the heme also influences the properties
of these enzymes. These residues play important roles in determining the polarity of the
proximal and distal heme environment, and the degree of the accessibility of the heme
iron center and heme edge.15 Indeed, metalloproteins that have exactly the same metal
centers can have different functions. For instance, though cytochromes P450 and
chloroperoxidase have identical thiolateligated heme iron at the active sites, cytochromes
P450 are mono-oxygenases, whereas chloroperoxidase halogenates substrates through a
similar mechanism.
So far, it has been shown that functions of hemoproteins rely on the nature of
heme, the proximal and axial ligand(s), and the non-ligand heme environment. In this
7

section heme enzymes cytochromes P450, hemoglobin and myoglobin, catalases,
peroxidases, and catalase-peroxidases are taken as examples to better understand how
heme environment influences the function of heme enzymes.
1.4

Heme dioxygenase
Heme dioxygenase, including indoleamine 2,3-dioxygenase (IDO) and tryptophan

2,3-dioxygenase (TDO), are members of the family of heme-dependent enzymes, which
catalyze the O2-dependent oxidation of L-tryptophan to N-formylkynurenine in
tryptophan catabolism.16 PrnB is also considered to belong to the heme dioxygenase
family based on structural similarity between PrnB with IDO and TDO. However, the
sequence homology between PrnB and these two enzymes is poor. De Laurentis et al
proposed that PrnB shares a key catalytic step with IDO and TDO.2 Consequently, the
structure and reaction mechanism of heme dioxygenase are important for the
investigation of the catalytic mechanism and in vitro catalytic activity of PrnB.
The first structure published was recombinant human IDO, which was
crystallized with 4-phenylimidazole(colored in blue) bound to the heme iron(Figure
1.10).17 There is a proximal histidine residue (His346, colored in yellow) binding to the
heme iron in the active center. This confirmed some early predictions about the heme
ligation based upon spectroscopic data reported from Forouhar Farhad et al.18 IDO
contains a large number of hydrophobic Phe and Tyr aromatic residues in the substrate
binding pocket which are expected to stablize binding of the tryptophan substrate.
However, there is no basic residue inthis pocket which will be difficult for the abstraction
of indole proton in the proposed mechanism.18
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Later the crystal structure of the bacterial X. Campestris TDO was reported and its
active sites showed the highly structural similarity to the IDO active sites(Figure 1.11).19
The TDO with the active site contains a distal histidine residue (His55, colored in
yellow). Interestingly this structure also proved insight to the binding interactions that
stable the substrate as it binds to the hydrophobic pocket in order to let the catalyze
reaction happen.
The catalytic mechanisms of TDO and IDO have been throughly investigated,
however, it still has several unsolved steps. The first step of the mechanism had been
proposed as a base-catalyzed abstraction of the indole proton, and several other
alternative mechanisms are reviewed.16,20 The second step processes via a Criegee
rearrangement mechanism involves the formation of a tryptophan hydroperoxide
intermediate.19, 21 The other proposed mechanism involves a dioxetane mechanism with
the formation of a four-membered dioxetane ring involved.17 The two proposed
mechanisms are showed in Figure 1.12.
The topology of the core helical domain of PrnB is very similar to that of both
IDO and TDO, and the heme binding site is located in approximately the same position in
all structures.2 Both PrnB and IDO are monomers and contain the small N-terminal
domain which helps to form the heme binding pocket. This degree of similarity would
point to a functional relationship, at least for the key catalytic step, between IDO/TDO
and PrnB. The crystal structures of PrnB with L-tryptophan complexes suggests that
PrnB shares a similar indole binding pocket with IDO, however, the pocket of PrnB
prefers binding with larger chlorinated substrates. Other differences in the active site
have resulted in a significant change in redox potential at the heme and in the orientation
9

of the tryptophan at the iron center. PrnB does have a different architecture on the distal
face to TDO/IDO. This is mirrored in its different redox potential and in differences in
the indole binding site. It has been proposed that all these differences prevent PrnB from
stabilizing the Criegee intermediate and stop tryptophan dioxygenase chemistry. And the
native catalytic mechanism of PrnB is still under investigation.
Alternative oxygen activation pathways have been very well explored in some
other heme-containing enzymes.17 Figure 1.13 summarized the various reaction
mechanisms for different heme enzymes. This overall heme-containing enzymes
mechanism is possible to help us to discover some non-native type catalytic activities for
PrnB in vitro.

Figure 1.1

Molecular structure of pyrrolnitrin
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Figure 1.2

Pyrrolnitrin biosynthetic pathway

Figure 1.3

Gene cluster required for pyrrolnitrin biosynthesis
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Figure 1.4

Crystal structure of PrnA, PDB ID: 2JKC.

Notes: The FAD group is colored in red and the substrate L-tryptophan is colored in
yellow. Also W272 and W274 are colored in yellow while K79 is colored in purple. The
Cl- ions are shown as a blue sphere.
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Figure 1.5

Generation of HOCl.

Notes: The generation of HOCl by PrnA requires a nucleophilic attack of Cl- on the
peroxy-flavin.
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Figure 1.6

Proposed halogenation of tryptophan proceeds by electrophilic aromatic
substitution at the 7 position

[ ]

Figure 1.7

Proposed PrnD reaction mechanism
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L-Trp

His 313

Figure 1.8

Crystal structure of PrnB with its native type substrate L-tryptophan, PDB
ID: 2V7J.

Notes: The heme group is colored in blue and the central iron is colored in red.
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Figure 1.9

Structure of most common hemes
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4-phenylimidazole

His 346

Figure 1.10

Crystal structure of human TDO with 4-phenylimidazole, PDB ID: 2DOT.

Notes: The heme group is colored in red.

17

His 55

Figure 1.11

Crystal structure of X. Campestris TDO, PDB ID: 2NW7.

Notes: Heme group is colored in red.
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Figure 1.12

Two mechanic pathways for the second steps catalyzed by TDO and IDO
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Figure 1.13

Summary of the reaction mechanisms of various heme enzymes
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CHAPTER II
EXPRESSION, PURIFICATION, IN VITRO CATALYTIC ASSAYS AND
INHIBITION STUDY OF PRNB

2.1

Expression and Purification of PrnB
The cloning, expression, purification, and crystallization of PrnB in Pseudomonas

fluorescens (BL915) have been reported.22 The Burkholderia ambifaria genes associated
with the prnABCD cassette were cloned and incorporated into the pET28a vectors to
create expression systems for each gene. The pCR1, pCR2, pCR3, and pCR4 correspond
to the expression systems to generate the His-TAG modified PrnA, PrnB, PrnC and PrnD,
respectively. This molecular biology was performed by NorClone (London, Ontario,
Canada).
The plasmid containing the B. ambifaria PrnB gene (pCR2) was transformed into
E. coli Rosetta2 (DE3) cells originally purchased from Agilent Technologies, and these
cells were plated onto a solid media plate with 50 mg/L kanamycin. Bacterial colonies of
E. coli Rosetta2 (DE3) [pCR2] were used to inoculate LB medium with 50 mg/L
kanamycin. For the production of recombinant proteins, E. coli expression strains
carrying the expression vectors were grown to an O.D600 between 0.6 and 1.0. The
protein expression was induced by adding 1mM Isopropyl β-D-thio-galactopyranoside
(IPTG). After induction, the cells were incubated with shaking for 4 addition hours at 37
21

℃. Bacterial cells were collected by centrifugation at 13,000 x g (25 min at 4 ℃), then
frozen at – 80 ℃.

The E. coli. cells containing PrnB were thawed and then sonicated with a Branson

Sonifier 250 to rupture the bacterial cells. The lysed cells were then spun in a centrifuge
to separate the supernatant from the cellular debris. The supernate was collected and
applied to a Ni-NTA affinity column. The Ni-NTA column is designed for purification of
6 x His-tagged recombinant proteins expressed in bacteria, insect, and mammalian cells.
The column is designed around the high affinity and selectivity of Ni-NTA Agarose for
recombinant fusion proteins that are tagged with six tandem histidine residues. The
resulting proteins are ready for use in many target applications. It needs to be regenerated
before use as follows: washed with 20 ml water, stripped with 20 ml 50 mM EDTA and
after a further wash step with 20 ml water, loaded with 10 ml 400 mM NiSO4 and washed
again. Prior to use the Ni-NTA column was washed by 15 ml of binding buffer. Then the
protein supernatant solution was applied to the column and the flow through retained for
analysis. The column was washed with washing buffer until all the unbound proteins
were removed from the column. Bound proteins were eluted applying the elution buffer
containing 250 mM imidazole. The protein content of eluted fractions was analyzed by
SDS-PAGE. The fractions, which contained the purified protein was concentrated by
amicon and the buffer was exchanged in order to remove imidazole. Buffer compositions
are listed in Table 2.1.
Concentration of PrnB was initially determined using Bio-Rad Protein assay.
Commercial purchased horseradish peroxidase (HRP) was used as standard. The result of
SDS-PAGE was shown in Figure 2.1. From the figure we can see that the over-expressed
22

protein owned a molecular weight which is a little bit larger than 37 KDa, which is close
enough to the MW of PrnB (39 KDa). The HRP standard solutions were incubated with
dye as described in the bio-rad assay mannual to generate a linear calibration curve
(Figure 2.2). A 10 µl aliquot of PrnB from the stock was added to 90 µl of BES buffer to
make the protein that was incubated with biorad assay dye in a similar situation as the
HRP standard. The average absorption value is 0.4123, from which the concentration of
the PrnB stock sample was calculated to be 0.785 mg/ml. Using the molecular weight of
PrnB, which is 39502 Da, the concentration of PrnB stock is 200 µM. This stock solution
was used for UV-Vis analysis where a molar absorption coefficient was calculated for
both the PrnB 280nm and 405 nm absorption transition (∈280 = 37,000 M-1cm-1, ∈405 =
60,550 M-1cm-1).

The UV-Visible absorption spectra of PrnB were recorded by a modernized Cary
14 UV/Vis/NIR spectrophotometer. The buffer used here is 20 mM BES with 3%
glycerol at pH 6.5. Heme-containing enzymes have the protein absorption peak at 280 nm
(∈280 = 37,000 M-1cm-1) and also a strong visible transition known as the soret band
405nm (∈405 = 60,550 M-1cm-1). The ratio of the two peaks yields information on the
oxidation state of the iron. The as-isolated PrnB was titrated with both oxidant (H2O2)
and reductant (DTT) to measure spectroscopic changes associated with redox states.
As dithiothreitol was added into the solution, the soret transition at 405 nm lost
intensity and the protein band at 280 nm increased in intensity (Figure 2.3). The decrease
of the 405 nm transition is consistent with iron went becoming reduced.2 This data
suggest the oxidation state of iron in the as-isolated PrnB is in the +3 oxidation state, and
can be reduced directly to the ferrous oxidation state. However, the absorption spectra of
23

PrnB showed no change by adding H2O2 (figure not shown here) while the iron couldn’t
switch to a higher oxidation state with oxidant added. The as-isolated oxidized PrnB has
a more intense peak at 405 nm than 280 nm, where the ratio is about 1.64. This ratio
changed to be smaller after PrnB was reduced.
2.2
2.2.1

In vitro Catalytic Activity Assays
The native activity of PrnB
The proposed catalytic activity of PrnB involved a unique ring rearrangement

from 7-Cl-tryptophan to monodechloroaminopyrrolnitrin, which has been demonstrated
as a in vivo in P. fluorescens.23 But this activity has never been found in vitro. A number
of possible reason have been proposed for this lack of activity.2 There could be a required
unknown co-factor that has yet to be determined, or there could be a required structural
interaction that is needed to support this reactivity, such as a complex of four proteins
involved in pyrrolnitrin biosynthesis may be needed to interact with PrnB to stimulate
reactivity.
Upon isolating B. ambifaria PrnB, we aimed to explore the proposed reactivity of
PrnB in vitro. A stock buffer solution (20 mM BES with 3% glycerol at pH 6.5) was used
for all solutions. Solutions of DTT and tryptophan were generated by weighing the
purified solids on an analytical balance and dissolving these compounds in 20 mM BES
at pH 7. The reaction sample was prepared with 10 µL of 1 mM tryptophan, 40 µL of 1
mM DTT, and 75 µL of PrnB, which were added to 875 µL of 20 mM BES buffer under
aerobic condition. These reaction solutions were allowed to react for two days. At the
same time, control samples have also been prepared for the analysis of the result. Control
1 was made by adding 10 µL of 1 mM Trp into 990 µL buffer. Control 2 was made by
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adding 40 µL of 1 mM DTT into 960 µL buffer. Control 3 was made by adding 10 µL of
1 mM Trp and 40 µL of 1 mM DTT into 950 µL buffer. The reaction samples were
filtered by using a 10,000 MW cut-off filter in an Amicon microcon. The solutions which
passed-through the filter were analyzed by HPLC and the results were shown in Figure
2.4. In Figure 2.4, the tryptophan signal has decreased intensity in the reaction sample
compared to the controls. In addition, a very polar unknown complex (3), which initially
was a single peak with low intensity, dramatically grows in intensity and becomes more
complex indicating new species are forms. These results shown that tryptophan is
consumed in a reaction catalyzed by PrnB. However, we have had substantial trouble
separating these polar species and have yet to characterize these highly polar compounds.
The heme active center is also found in a diverse number of other proteins that
have physiological roles related to reversible dioxygen binding to hydrogen peroxide
activation. Most heme enzymes have basal levels of aberrant activity that could be used
as a means of probing substrate binding. We have used an alternative peroxidase
reactivity of PrnB to study how amino-acids and related organic molecules interact with
the substrate binding site in PrnB.
Peroxidases are abundant enzymes present in all organisms and participate in a
wide variety of biological processes, the most important of which are involved in the
response to oxidative stress.24 Peroxidases can be classified into two distinct groups, the
so-called animal peroxidases, and plant peroxidases. Most plant peroxidases utilize ferric
heme b as the prosthetic group. In contrast, the heme utilized in most animal peroxidases
is covalently linked to the enzyme.25,26 The plant peroxidases share similar folding
features and active sites, and can be further divided into three classes based on their
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sequence comparison.27 Class I contains the intracellular enzymes, including yeast
cytochrome c peroxidase, ascorbate peroxidase, and bacterial gene-duplicatedcatalaseperoxidases. These peroxidases function as peroxide scavengers to protect cells. Class II
contains the secretory fungal peroxidases, such as lignin peroxidase, manganese
peroxidase from Phanerochaete chrysosporium, as well as Arthromyces ramosus
peroxidase. The main role of class II peroxidases is to degrade lignin in wood, and
participate in secondary metabolism under conditions of limited nutritional supply.28
Class III contains the secretory plant peroxidases such as peroxidases from horseradish,
barley, and soybean. They play important roles in defense and stress related processes, as
well as lignin synthesis and auxin degradation.
Heme peroxidases were first detected in plants and animals in the 19th century
and named as such by Linossier.29 Heme peroxidases are abundant enzymes present in all
living things that participate in a variety of physiological processes. All heme peroxidases
utilize heme iron to transfer electrons from a reducing substrate to H2O2. As discussed in
part 1.3, all heme peroxidases share the same catalytic mechanism as HRP.
2.2.2

pH dependent o-dianisidine assay
A modified method from a previous published literature was used here.30 The

buffer used for stock solutions of protein and hydrogen peroxide was 20 mM BES with
3% glycerol at pH 6.5. The buffer for all assay measurements and all other solutions
stock was 20 mM PIPES, 20 mM HEPES and 20 mM CHES at varied pH value (pH 6.0,
6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10.0). Each pH was fixed for the pH study and the buffer
was a cocktail of buffers. Bicarbonate (20 µL of 500 mM), o-dianisidine (20 µL of 2.5
mM), PrnB (5 µL of 200 µM) were added to the assay buffer (PIPES, HEPES, CHES,
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1440 µL of 20 mM of each). The reaction was initiated by adding the last ingredient
hydrogen peroxide (20 µL of 20 mM) to a totally volume of 1505µL. The rate constant
was determined from the spectophotometrical measurements at 460nm of the resulting
red-oxidation product (ε = 11,300 M-1cm-1) which is shown in Figure 2.5.31 Each
experiment was repeated at least three times in each case until the results obtained were
almost consistent.
2.2.3

pH dependent catechol-aniline assay
A modified method from a previous published literature was used here.32 The

buffer used for stock solutions of protein and hydrogen peroxide was 20 mM BES with
3% glycerol at pH 6.5. The buffer for all assay measurements and all other solutions
stock was 20 mM PIPES, 20 mM HEPES and 20 mM CHES at varied pH value (pH 6.0,
6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10.0). Mixture of catechol (170 mM) and aniline (2.5 mM)
was prepared in a 20mM BES pH 6.5 buffer. 450µL of the above mixture was added to
cuvettes with 500µL of hydrogen peroxide (1.7 mM). Wait for 2 min to achieve a
temperature equilibration for the mixture and then 50 µL of 20 mM PIPES, 20 mM
HEPES and 20 mM CHES buffer and 5 µL of PrnB (200 µM) were added to initiate the
reaction. The rate was determined from the spectophotometrical measurements at 510 nm
of the formation of the colored product of 4-(phenylamino)-benzene-1,2-diol (ε510 =
5,000 M-1cm-1), shown in Figure 2.6. Each experiment was repeated at least three times in
each case until the results obtained were almost consistent.
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2.2.4

pH dependent 2-aminophenol (OAP) assay
The buffer used for stock solutions of protein and hydrogen peroxide was 20 mM

BES with 3% glycerol at pH 6.5. The buffer for all assay measurements and all other
solutions stock was 20 mM PIPES, 20 mM HEPES and 20 mM CHES at varied pH value
(pH 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, 10.0). 2-aminophenol (20 µL of 50 mM),
hydrogen peroxide (20 µL of 20 mM) were added to the 20 mM PIPES, 20 mM HEPES
and 20 mM CHES buffer (960µL). To initiate the reaction, PrnB (5 µL of 200 µM) was
added to a total volume of 1005 µL. The rate was determined from the
spectophotometrical measurements at 434 nm of the formation of 2-amino-3Hphenoxazin-3-one (APX, ε = 23,200 M-1cm-1) which is shown in Figure 2.7. Each
experiment was repeated at least three times in each case until the results obtained were
almost consistent.
2.2.5

Results
All the three assays used for the in vitro catalytic activity study of PrnB were also

catalyzed by horseradish peroxidase (HRP). As it was truly difficult to perform the native
catalytic activity of PrnB in vitro, these three peroxidase assays were applied to PrnB in
vitro due to its partial active center similarity with HRP to investigate the in vitro
catalytic activity of PrnB. The HRP was used as the catalytic activity reference for PrnB.
2.2.5.1

Result of o-dianisidine assay for both PrnB and HRP at varied pH value
The in vitro catalytic activity of PrnB on o-dianisidine assay compared with

horseradish peroxidase is shown in Figure 2.8. Previous work showed that the optimal pH
for horseradish peroxidase catalyze the oxidation of o-dianisidine is 5.8, which is
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coincide with the results shown in Figure 2.8.33 Compared to HRP, PrnB showed much
more than a thousand times weaker catalytic activity. However, this catalytic activity of
PrnB for o-dianisidine oxidation is still useful as a starting point for studying PrnB and
can be used for inhibition study in future.
2.2.5.2

Result of catechol-aniline assay for both PrnB and HRP at varied pH
value
The in vitro catalytic activity of PrnB on catechol-aniline assay as a function of

pH compared with horseradish peroxidase is shown in Figure 2.9.
Based on the result shown in Figure 2.9, horseradish peroxidase functions better
at relative low pH values. As the pH value is increased for the solution, the catalytic
activity of HRP will be decreased, which is similar with the result obtained for odianisidine assay. PrnB shows only strong activity at low pH (pH=6). This activity is
similar to the value for HRP. The catalytic activity at all other pH values is much lower.
This assay leads to much better results for catalytic activity of both PrnB and HRP, which
is because the catechol-aniline mixture can be served as a better hydrogen donor
mediating couple for peroxidase.32
2.2.5.3

Result of 2-aminophenol assay for both PrnB and HRP at varied pH value
The in vitro catalytic activity of PrnB on 2-aminophenol assay compared with

horseradish peroxidase is shown in Figure 2.10. In the top panel of Figure 2.10, it is
evident that horseradish peroxidase is more efficient at relative low pH values. Compared
to the catalytic activity of HRP, PrnB showed much weaker activity in this assay.
However, the overall pH dependence is highly interesting as PrnB showed no catalytic
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activity at the range where HRP works best, and PrnB shows better activity at relative
high pH values.
From this part we can see that PrnB have some peroxidase activity in all three of
these assays, which suggest that PrnB is able to utilize hydrogen peroxide to catalyze
reactions. However, its peroxidase-like catalytic activity is just about one thousand times
of the traditional peroxidase HRP in most situations. As a result, it can be used for further
inhibitor study, which might be helpful for understanding the catalytic mechanism of
PrnB or at least how these substrates bind to the active center of PrnB. The interesting
point is that the performance of HRP is much better at a relative low pH, while PrnB
prefer a higher pH value for the 2-aminophenol assay. This shows us that some basic
amino acids may play a key role in the catalytic process.
As PrnB has showed catalytic activities in vitro, these peroxidase assays can be
used as model assay to continue the inhibitor study for PrnB, where the inhibitors will
also possibly influence the native activity of PrnB.
2.3
2.3.1

Inhibition Study of PrnB Based on 2-Aminophenol Assay
Materials and Methods
The model assay used to perform the inhibition study for PrnB is the 2-

aminophenol assay which was described from 2.2. The inhibitors we used here included:
(1) L-tryptophan, which is the native type substrate of PrnB. (2) L-alanine and indole,
which can be considered as the two constituent parts of L-tryptophan. (3) L-phenylalaine
and L-tyrosine, which are related amino acids, similar to L-tryptophan (shown in Figure
2.11). The buffer for protein stock was 20 mM BES with 3% glycerol, at pH 6.5. The
buffer for all the assay measurements and all other solution stock was 20 mM BES, at pH
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8.0. The 2-aminophenol (50 µL of 10 mM), inhibitors (varied concentrations with various
volume), and PrnB (20 µL of 50µM) were added to the assay buffer (20 mM BES, pH
8.0, the volume was adjusted with the volume of inhibitors to make a total volume of
1000 µL). To start the reaction, hydrogen peroxide (20 µL of 50 mM ) was added. The
rate constant was determined from the spectophotometrical measurements at 434 nm of
the formation of 2-amino-3H-phenoxazin-3-one (ε = 23,200 M-1cm-1). The experiments
were repeated at least three times in each case until the results obtained were almost
consistent.
2.3.2

Results
The results of the inhibition of the catalytic activity on 2-aminophenol assay for

PrnB were shown as the activity percentage plotted against with the concentration of
inhibitors (Figure 2.12). The activity percentage is that the rate with certain concentration
of one inhibitor divided by the rate with no inhibitor. The lower activity percentage is
indicating of a more potent inhibitor.
The data reported in Figure 2.12 shows that L-tryptophan has dramatic effect on
the inhibition of the catalytic activity of PrnB on the 2-aminophenol assay, where the IC50
is 15µM. This is mainly on account that L-tryptophan is the native type substrates of
PrnB, which is able to occupy the catalytic active center of PrnB with high affinity. As a
result, L-tryptophan must block the access pathway of 2-aminophenol to the catalytic
active center of PrnB. To study the inhibition type of L-tryptophan, Lineweaver-Burk
plots for the enzymatic reaction in the presence and absence of L-tryptophan at its IC50
(15 µM) were plotted (Figure 2.13). The result suggest that L-tryptophan is mixed
noncompetitive inhibitor for 2-aminophenol assay, which means that L-tryptophan inhibit
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the reaction in both competitive and noncompetitive manner. So it’s possible for Ltryptophan and 2-aminophenol to interact with same and different sites of the active
center of PrnB, however, the binding affinity to PrnB of L-tryptophan is much better than
that of 2-aminophenol.
As the constituent parts of tryptophan, the combination of indole and L-alanine
should have the comparable inhibition effects with L-tryptophan after they were added to
the solution together. However, it showed no inhibition effects. Individually indole and
alanine also show limited inhibition effects. Previous work mentioned that there are
several types of binding interactions including hydrogen bonds and ionic interactions
with the surrounding residues to hold the substrate inside the active center.16,34 As a result
we propose that L-tryptophan has extremely strong binding interactions inside the active
center pocket so that it stays stable in the active center. The indole part of L-tryptophan is
so large that it is able to block the access pathway of other molecules. When it comes to
indole and alanine, indole must not possess that strong binding interaction with the active
center, without the amino acid moiety. Alanine is such a small molecule that it can’t
block other molecules to access to the heme center without indole, which lead to its
limited inhibition effects.
L-phenylalanine and L-tyrosine are analogs to L-tryptophan and both of them also
showed some inhibition effect, and L-tyrosine is slightly better with an IC50 value of
400µM. But the inhibition effect for both L-phenylalanine and L-tyrosine are smaller
than the inhibition effect of L-tryptophan. As L-phenylalanine and L-tyrosine showed
inhibition effects, it means there are binding interactions between them and the active
pocket. The side chain of all these three molecules is L-alanine. There is a benzene ring
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connecting to the alanine part for L-phenylalanine while a phenol ring connecting to the
alanine part for L-tyrosine. Both benzene and phenol are smaller than indole. As a result,
the ability of L-phenylalanine and L-tyrosine to block the access of other molecules to the
active center should be weaker that L-tryptophan.
The inhibition type of L-tyrosine was also studied by Lineweaver-Burk plots for
the enzymatic reaction in the presence and absence of L-tyrosine at its IC50 (400 µM),
shown in Figure 2.14. The result suggest that L-tyrosine is noncompetitive inhibitor for
2-aminophenol assay, which means L-tyrosine binds to a different site with 2aminophenol.
2.4

Summary
The cloning, expression, and purification of PrnB in Burkholderia ambifaria have

been successfully accomplished. It has also shown that the as-isolated PrnB is able to
utilize H2O2 to catalyze a number of classic peroxidase assays in vitro. Compared to
HRP, the peroxidase-like catalytic activity of PrnB is just about one thousand times in
most situations, however, this alternative peroxidase activity could be employed to better
understand the dynamics of how amino-acids bind to the substrate binding pocket in the
absence of the proposed oxygenase reactivity for this enzyme. The 2-aminophenol
peroxidase assay has been used as the model reaction to perform inhibition study for
PrnB in vitro with several different types of inhibitors. As the native type substrate, Ltryptophan showed dramatic inhibition efficiency for this reaction and has been further
proved to be the mixed competitive and noncompetitive type inhibitor. It can be proposed
that the binding sites of L-tryptophan and 2-aminophenol have some overlaps, but the
binding affinity of L-tryptophan to the catalytic pocket is much better that 233

aminophenol. As a result, adding L-tryptophan to the 2-aminophenol reaction will
decrease the catalytic activity. At the same time, L-tyrosine has been proved to be the
noncompetitive type inhibitor. It showed weaker inhibition efficiency compared to Ltryptophan with an IC50 value of 400 µM.
Table 2.1

Buffer compositions
Binding Buffer

Washing Buffer

Elution Buffer

BES 20 mM pH 7.0

BES 20 mM pH 7.0

BES 20 mM pH 7.0

NaCl 300 mM

NaCl 300 mM

NaCl 300 mM

Imidazole 2 mM

Imidazole 10 mM

Imidazole 250 mM

Figure 2.1

Result of SDS-PAGE
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Figure 2.2

The linear graph of the absorption of HRP standard versus concentration

Figure 2.3

UV-Visible absorption spectra of PrnB with varing concentration of DTT
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Figure 2.4

In vitro native activity study of PrnB with tryptophan as substrate.

Notes: (a) Control 1, (b) Control 2, (c) Control 3, (d) Control 4. Peak 1 stands for
tryptophan, peak 2 stands for DTT and peak 3 is unknown compound. The mobile phase
is 80% Water and 20% MeOH with a flow rate of 1ml/min.
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Figure 2.5

PrnB and HRP catalyzed the oxidation of o-dianisidine with hydrogen
peroxide

Figure 2.6

PrnB and HRP catalyzed catechol-aniline assay with hydrogen peroxide

Figure 2.7

PrnB and HRP catalyzed 2-aminophenol assay with hydrogen peroxide
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Figure 2.8

In vitro catalytic activity of oxidation of o-dianisidine by PrnB compared
with HRP
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Figure 2.9

In vitro catalytic activity of catechol-aniline assay by PrnB compared with
HRP
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Figure 2.10

In vitro catalytic activity of 2-aminophenol assay by PrnB compared with
HRP
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Figure 2.11

List of inhibitors

Figure 2.12

The effects of all inhibitors at varied concentrations on the catalytic activity
of PrnB in 2-aminophenol assay
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Figure 2.13

Lineweaver-Burk plot of PrnB activity on 2-aminophenol assay in the
presence and absence of 15 µM L-tryptophan.

Notes: The units of Y and X axes are (s µM-1) and (L mol-1), respectively. Top panel:
substrate concentration in all range. Bottom panel: substrate concentration in linear range.
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Figure 2.14

Lineweaver-Burk plot of PrnB activity on 2-aminophenol assay in the
presence and absence of 400 µM L-tryptophan.

Notes: The units of Y and X axes are (s µM-1) and (L mol-1), respectively. Top panel:
substrate concentration in all range. Bottom panel: substrate concentration in linear range.
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APPENDIX A
HORSERADISH PEROXIDASE (HRP)
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Horseradish peroxidase (HRP) is the archetypal heme peroxidase that has been
investigated for more than a century.35 It is a globular glycoprotein with a molecular
weight of 42 KDa, of which the protein moiety is about 34 KDa, the rest is the prosthetic
group b-type heme, two calcium ions and some surface binding glycans. The most
abundant type of HRP is the horseradish peroxidase isoenzyme C. Peroxidases are
important type of enzyme which are related to diverse biological process including cell
wall synthesis and degradation, stress response, signaling of oxidative stress and removal
of xenobiotics.36 HRP is chosen as the peroxidase to be studied for a long time and a lot
of informations like three-dimensional structure of the enzyme, catalytic intermediates,
mechanisms and the function of some specific amino acids of the enzyme are available
for us to have a better understanding of HRP.
The crystal structure of HRP (shown in Figure A.1) showed that the enzyme
contains two types of metal center, heme iron and two calcium ions.35 All of the metals
are essential for the structural and functional integrity of the enzyme. As shown in Figure
A.1, the heme group (red) is located in the middle of the distal and proximal domains,
each of which contains a calcium atom (blue). It’s the His170 (the proximal histidine
residue, shown in yellow) that coordinated to the heme group while the the diatal site is
empty which is available for substrates and hydrogen peroxide during enyzme turnover.
The two calcium sites can be linked to the heme region by hydrogen bonding interactions
and the loss of calcium will lead to decrease to both enzyme activity and thermal
stability.34
Horseradish peroxidase is able to catalyze numerous peroxidase reactions and the
catalytic mechanism has been investigated extensively. The HRP general mechanism is
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illustrated in Figure A.2.36 The first step in the catalytic cycle is H2O2 reacting with the
Fe(III) resting state of the enzyme to produce compound I, which is a high oxidation state
intermediate containing an Fe(IV)=O heme+• center. A transient intermediate (compound
0) formed prior to compound I has been detected in reactions between HRP and H2O2 at
low temperatures and described as an Fe(III)-hydroperoxy complex. The first oneelectron reduction step requires the participation of a reducing substrate and leads to the
generation of compound II, an Fe(IV) oxoferryl species that is one oxidizing equivalent
above the resting state. The second one-electron reduction step returns compound II to
the resting state of the enzyme. This general mechanism can be applied extensively for
many peroxidase enzymes and different peroxidase reactions.
Even though PrnB is a putative heme dioxygenase, it owns sequence and structure
similarity with HRP, especially the active centers are quite similar. There is a proximal
histidine ligand binding to the heme iron for both enzymes and the oxidation state of iron
of the purified PrnB is same with HRP. As a result, we propose that PrnB is possible to
perform some peroxidase-like activities in vitro as HRP.
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His 170

Figure A.1

Crystal structure of HRP, PDB ID: 1ATJ
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Figure A.2

HRP general mechanism36
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